• 
  Ramdane Igalouzene. Etude du rôle de SMAD4 dans les lymphocytes T CD8+ au niveau de la muqueuse intestinale. Immunologie. Université de Lyon, 2021. Français. ⟨NNT : 2021LYSE1227⟩. ⟨tel-03957039⟩
• 
  G.S. Roth, C. Neuzillet, M. Sarabi, J. Edeline, D Malka, et al.. Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?. European Journal of Cancer, 2023, 179, pp.1-14. ⟨10.1016/j.ejca.2022.11.006⟩. ⟨hal-03931293⟩
• 
  Violaine Randrian, Simon Pernot, Karine Le Malicot, Vittorio Catena, Isabelle Baumgaertner, et al.. FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer. Digestive and Liver Disease, 2022, 54 (7), pp.857-863. ⟨10.1016/j.dld.2022.04.024⟩. ⟨hal-03906999⟩
• 
  Coline Montégut, Jean-Sébastien Guillamo, François Ducray, Caroline Dehais, Elisabeth Cohen-Jonathan Moyal, et al.. Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network Study. Cancers, 2022, 14 (22), pp.5509. ⟨10.3390/cancers14225509⟩. ⟨hal-03881443v2⟩
• 
  Guillaume Gauchotte, Charles Bédel, Emilie Lardenois, Sébastien Hergalant, Laura Cuglietta, et al.. A high MCM6 proliferative index in atypical meningioma is associated with shorter progression free and overall survivals. Cancers, 2023, 15 (2), pp.535. ⟨10.3390/cancers15020535⟩. ⟨hal-03950329⟩
• 
  Jessica Azzi, Céline Dorival, Carole Cagnot, Hélène Fontaine, Clovis Lusivika-Nzinga, et al.. Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response. Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (6), pp.101923. ⟨10.1016/j.clinre.2022.101923⟩. ⟨hal-03651922⟩
• 
  Lea Jabbour. Role of the Bcl-2 family of cell death regulators at the Endoplasmic Reticulum. Molecular biology. Université de Lyon, 2020. English. ⟨NNT : 2020LYSE1031⟩. ⟨tel-03917119⟩
• 
  Adrien Bertrand-Chapel, Cassandre Caligaris, Tanguy Fenouil, Clara Savary, Sophie Aires, et al.. SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4. Communications Biology, 2022, 5 (1), pp.1068. ⟨10.1038/s42003-022-03994-6⟩. ⟨hal-03915470⟩
• 
  Alice Bonneville-Levard, Didier Frappaz, Olivier Tredan, Emilie Lavergne, Véronique Corset, et al.. Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial. Medical Oncology, 2021, 39 (1), pp.4. ⟨10.1007/s12032-021-01536-4⟩. ⟨hal-03915456⟩
• 
  Elise Bonnet, Véronique Haddad, Stanislas Quesada, Kim-Arthur Baffert, Audrey Lardy-Cléaud, et al.. Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial. Journal of Personalized Medicine, 2022, 12, ⟨10.3390/jpm12101595⟩. ⟨hal-03915443⟩
• 
  Elise Peter, Isabelle Treilleux, Valentin Wucher, Emma Jougla, Alberto Vogrig, et al.. Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo–Associated Paraneoplastic Cerebellar Degeneration. Neurology Neuroimmunology & Neuroinflammation, 2022, 9 (5), pp.e200015. ⟨10.1212/nxi.0000000000200015⟩. ⟨hal-03915422⟩
• 
  Olivier Fesneau. Rôle du TGF-beta dans la biologie des lymphocytes Th17 déjà différenciés et leur impact dans l'inflammation chronique intestinale. Immunologie. Université de Lyon, 2019. Français. ⟨NNT : 2019LYSE1350⟩. ⟨tel-03907317⟩
• 
  Olivia Le Saux, Yasmine Lounici, Pauline Wajda, Sarah Barrin, Christophe Caux, et al.. Neoadjuvant immune checkpoint inhibitors in cancer, current state of the art. Critical Reviews in Oncology/Hematology, 2021, 157, pp.103172 -. ⟨10.1016/j.critrevonc.2020.103172⟩. ⟨hal-03492630⟩
• 
  J.-P. Foy, C. Bertolus, M.-C. Michallet, S. Deneuve, R. Incitti, et al.. The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade. Annals of Oncology, 2017, 28 (8), pp.1934-1941. ⟨10.1016/S0140-6736(19)31764-7⟩. ⟨hal-03895307⟩
• 
  Julie GIL, Isabelle Krimm, Vincent Dugas, Claire Demesmay. Preparation of miniaturized hydrophilic affinity monoliths: Towards a reduction of non-specific interactions and an increased target protein density. Journal of Chromatography A, 2023, 1687, pp.463670. ⟨10.1016/j.chroma.2022.463670⟩. ⟨hal-03888930⟩

779

1 219